News25/Ratings0
News · 26 weeks31+133%
2026-03-012026-08-23
Mix1290d
- Other7(58%)
- SEC Filings3(25%)
- Leadership1(8%)
- Insider1(8%)
Latest news
25 items- PRBaird Medical Expands Global Microwave Ablation Footprint with Additional Product Registrations in PakistanNEW YORK, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), announced that the BD-GT Microwave Ablation System and T-1610 Disposable Microwave Ablation Needle have received product registrations from the Drug Regulatory Authority of Pakistan ("DRAP"), further supporting the Company’s commercial activities in the country. The registrations build on Baird Medical’s existing presence in Pakistan, where the Company announced regulatory approvals and initial commercial availability at the Armed Forces Institute of Radiology & Imaging ("AFIRI") in January 2026. The latest registrations further expand the regulatory foundat
- SECSEC Form 424B3 filed by Baird Medical Investment Holdings Ltd424B3 - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- SECSEC Form EFFECT filed by Baird Medical Investment Holdings LtdEFFECT - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- SECSEC Form EFFECT filed by Baird Medical Investment Holdings LtdEFFECT - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- PRBaird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology GloballyAgreement combines Baird Medical's clinical, regulatory, and global commercialization expertise with Alpmed's leadership in IRE technologyCollaboration will advance technology development, global regulatory approvals, commercialization, and clinical adoption across key international markets, including the United States NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company") and Tianjin Yuanshan Medical Technology Co., Ltd., operating under the Alpmed brand ("Alpmed"), a China-based innovator in irreversible electroporation ("IRE") technology, announced the signing of a strategic cooperation agreement to establish
- SECSEC Form POS AM filed by Baird Medical Investment Holdings LtdPOS AM - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- SECAmendment: SEC Form F-3/A filed by Baird Medical Investment Holdings LtdF-3/A - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- SECSEC Form SCHEDULE 13D filed by Baird Medical Investment Holdings LtdSCHEDULE 13D - Baird Medical Investment Holdings Ltd (0001982444) (Subject)
- INSIDERNew insider Excelfin Spac Llc claimed ownership of 7,004,016 units of Ordinary shares (SEC Form 3)3 - Baird Medical Investment Holdings Ltd (0001982444) (Issuer)
- SECAmendment: SEC Form 20-F/A filed by Baird Medical Investment Holdings Ltd20-F/A - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- PRBaird Medical Announces First Microwave Ablation Procedures Using Its Technology in Vietnam and ArgentinaFirst procedures in two new markets highlight growing global adoption of Baird Medical's minimally invasive microwave ablation technology NEW YORK, June 29, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful completion of the first procedures using its MWA technology in Vietnam and Argentina. In Vietnam, the first clinical case using the Company's MWA technology was completed at Lac Viet Friendship Hospital on June 18. The procedure was performed by Dr. Dinh Xuan H
- PRBaird Medical Establishes Global Headquarters in New York City, Reinforcing Commitment to U.S. Commercial ExpansionEnhanced U.S. Presence Centralizes Operations as Company Executes Global Growth StrategyNEW YORK, June 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the relocation of its global headquarters to the U.S., with the establishment of a new corporate office in New York, NY. The relocation follows the December 2025 appointment of Mark Saxton as CEO of Baird Medical's U.S. subsidiary to lead domestic operations, commercial expansion, and market development, establishing a Compan
- SECSEC Form POS AM filed by Baird Medical Investment Holdings LtdPOS AM - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- SECSEC Form F-3 filed by Baird Medical Investment Holdings LtdF-3 - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- SECSEC Form SCHEDULE 13G filed by Baird Medical Investment Holdings LtdSCHEDULE 13G - Baird Medical Investment Holdings Ltd (0001982444) (Subject)
- PRBaird Medical Reports Full Year 2025 Financial Results and Provides Corporate UpdateFull year 2025 revenue of $22.5 million, impacted by policy-driven slowdown in Mainland ChinaAdvancing global expansion with appointment of seasoned commercial leader, Mark Saxton, as CEO of Baird Medical U.S. to lead commercial ramp in the United StatesNEW YORK, April 29, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its financial results for the full year ended December 31, 2025 and provided an update on key strategic and operational initiatives.
- SECSEC Form 20-F filed by Baird Medical Investment Holdings Ltd20-F - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- INSIDERSEC Form 3 filed by new insider Xu Lijian3 - Baird Medical Investment Holdings Ltd (0001982444) (Issuer)
- INSIDERSEC Form 3 filed by new insider Qiu Quan3 - Baird Medical Investment Holdings Ltd (0001982444) (Issuer)
- INSIDERSEC Form 3 filed by new insider Lu Rongjian3 - Baird Medical Investment Holdings Ltd (0001982444) (Issuer)
- INSIDERSEC Form 3 filed by new insider Bilciu-Wolfson Gabrielle3 - Baird Medical Investment Holdings Ltd (0001982444) (Issuer)
- INSIDERSEC Form 3 filed by new insider Li Jie Clara3 - Baird Medical Investment Holdings Ltd (0001982444) (Issuer)
- INSIDERSEC Form 3 filed by new insider Ragan Joseph Douglas Iii3 - Baird Medical Investment Holdings Ltd (0001982444) (Issuer)
- INSIDERSEC Form 3 filed by new insider Hou Wei3 - Baird Medical Investment Holdings Ltd (0001982444) (Issuer)
- INSIDERSEC Form 3 filed by new insider Wu Haimei3 - Baird Medical Investment Holdings Ltd (0001982444) (Issuer)
BDMD FAQ
4 questionsWhere does BDMD stock trade?
Baird Medical Investment Holdings Ltd (BDMD) is listed on NASDAQ.What sector and industry is BDMD in?
Baird Medical Investment Holdings Ltd operates in the Health Care sector, Medical/Dental Instruments industry.What companies are similar to BDMD?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare BDMD side-by-side with any of them on Quantisnow.How can I track BDMD on Quantisnow?
Quantisnow aggregates Baird Medical Investment Holdings Ltd's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BDMD to receive live email and push alerts on every new disclosure.